UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
Under the Securities Exchange Act of 1934
For the month of November 2024
Commission
File No.
(Exact Name of Registrant as Specified in Its Charter)
N/A | ||
(State
or other jurisdiction of incorporation or organization) |
(I.R.S.
Employer Identification No.) |
Scotland,
|
N/A | |
Address of Principal Executive Offices | Zip Code |
(Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐
INCORPORATION BY REFERENCE
The Company’s unaudited condensed consolidated financial statements as of June 30, 2024 and 2023 are attached as Exhibit 99.1 and are incorporated by reference herein. The Company’s Management’s Discussion and Analysis of Financial Condition and Results of Operations is attached hereto as Exhibit 99.2 and is incorporated by reference herein.
2 |
Exhibits
The exhibits required by the instructions to Form 6-K are listed in the Exhibit Index below. The exhibits listed in the Exhibit Index are incorporated by reference herein.
Exhibit | Description | Schedule/ Form | File Number | Exhibit | File Date |
99.1 | Unaudited condensed consolidated financial statements as of June 30, 2024 and 2023 | |
99.2 | The Company’s Management’s Discussion and Analysis of Financial Condition and Results of Operations | |
101.INS | Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document) | |
101.SCH | Inline XBRL Taxonomy Extension Schema Document | |
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | |
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | |
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |
104 | Cover Page Interactive Data File (formatted in IXBRL, and included in exhibit 101). |
3 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
TC BIOPHARM (HOLDINGS) PLC | ||
By: | /s/ Bryan Kobel | |
Bryan Kobel Chief Executive Officer | ||
By: | /s/ Martin Thorp | |
Martin Thorp Chief Financial Officer |
Date: November 25, 2024
4 |